DONGWHA PHARM CO LTD
http://dongwhap.tradekorea.com
Dong Wha is the company that “serves customers through making good medicines and is operated with the resulting revenues.” And it considers its customers’ health and safety to be the most important corporate philosophy on which to fulfill customer satisfaction. Dong Wha members consider themselves to be the owner of the company where “they are willing to work diligently in their youth and live fruitful lives in their old age.” Dong Wha respects each member’s value and ownership and serves every customer with trust and faith. Dong Wha announced the year 2008 to be the year of the beginning of change & innovation for sustainable growth and it pursues creativity development and quality improvement of every member and flexible innovation to corporate culture to rise up as the major player in global pharmaceutical business in the 21st century. Moreover, based on accumulated experiences and technologies from the 114 year history, Dong Wha succeeded in several new drug developments, including licensing-out of DW 1350 (anti-osteoporosis) to P&G (US) and Teijin (Japan) which was the largest technology transfer in the Korean pharmaceutical industry.
Company Introduction
Dong Wha is the company that “serves customers through making good medicines and is operated with the resulting revenues.” And it considers its customers’ health and safety to be the most important corporate philosophy on which to fulfill customer satisfaction.
Dong Wha members consider themselves to be the owner of the company where “they are willing to work diligently in their youth and live fruitful lives in their old age.” Dong Wha respects each member’s value and ownership and serves every customer with trust and faith.
Dong Wha announced the year 2008 to be the year of the beginning of change & innovation for sustainable growth and it pursues creativity development and quality improvement of every member and flexible innovation to corporate culture to rise up as the major player in global pharmaceutical business in the 21st century.
Moreover, based on accumulated experiences and technologies from the 114 year history, Dong Wha succeeded in several new drug developments, including licensing-out of DW 1350 (anti-osteoporosis) to P&G (US) and Teijin (Japan) which was the largest technology transfer in the Korean pharmaceutical industry.
Detailed Company Information
DONGWHA PHARM CO LTD
- Business Type Manufacturer
- Year Established 1897
- Location South Korea
- Main Markets Germany,Spain,Indonesia,Japan,Mexico,Portugal,U.S.A,Viet Nam
- Total Employees 501-1000 People
- Homepage www.dong-wha.co.kr
- President KI HWAN PARK
- Phone +82-2-2021-9342 02-778-4331
- FAX +82-2-757-4677
- Address 6-8F, 24, NAMDAEMUN-RO, 9-GIL, JUNG-GU, SEOUL, 04522, KOREA, Jung-gu, Seoul, Korea
- Product Category Health & Medical > Health > Pharmaceuticals
- Factory Information DONG WHA CHUNGJU PLANT 167, Chungjusandan 1-ro, Chungju-si, Chungcheongbuk-do, Korea
Additional Introduction
1997 is a very special year for Dong Wha Pharmaceutical Industrial Company Limited - it marks its centennial celebration. Every one of us at Dong Wha would like to extend our utmost gratitude to all who have encouraged and supported us for the past 100 years. It was back in 1897, when Korea was undergoing tremendous upheavals in the name of modernization, that Dong Wha started as the nation's first medicine company. Over the years, Dong Wha has grown and expanded, taking pride in the fact that the company is responsible for safeguarding the public health.